SFI
TDOC icon

Susquehanna Fundamental Investments’s Teladoc Health TDOC Stock Holding History

Susquehanna Fundamental Investments’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-345,441
Closed -$3.14M – 1227
2024
Q4 		$3.14M Buy
+345,441
New +$3.34M 0.04% 430
2024
Q2 		$2.6M Buy
265,513
+65,767
+33% +$802K 0.06% 348
2024
Q1 		$3.02M Buy
+199,746
New +$3.62M 0.14% 177
2023
Q4 		– Sell
-22,304
Closed -$415K – 305
2023
Q3 		$415K Sell
22,304
-104,668
-82% -$2.44M 0.03% 270
2023
Q2 		$3.21M Sell
126,972
-79,642
-39% -$2M 0.12% 189
2023
Q1 		$5.35M Sell
206,614
-25,357
-11% -$679K 0.12% 210
2022
Q4 		$5.49M Buy
+231,971
New +$6.25M 0.09% 275
2021
Q1 		– Sell
-2,000
Closed -$400K – 1614
2020
Q4 		$400K Sell
2,000
-54,400
-96% -$11.1M 0.01% 1175
2020
Q3 		$12.4M Hold
56,400
– – 0.37% 39
2020
Q2 		$10.8M Buy
+56,400
New +$9.88M 0.51% 29

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna Fundamental Investments's TDOC Position: Q1 2025 in Review

Susquehanna Fundamental Investments sold out of Teladoc Health (TDOC) in Q1 2025, closing a stake of 345,441 shares — an estimated $3.14M sold.

Susquehanna Fundamental Investments first reported a position in TDOC in Q2 2020 and held it in 10 quarters. The position peaked at $12.4M in Q3 2020. 384 funds tracked by Wall St. Rank hold TDOC as of Q1 2025.

  • Susquehanna Fundamental Investments reported no remaining Teladoc Health position as of Q1 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 345,441 Teladoc Health shares in Q1 2025, an estimated $3.14M.
  • Susquehanna Fundamental Investments first reported a position in Teladoc Health in Q2 2020 and held it in 10 quarters.
  • Susquehanna Fundamental Investments's Teladoc Health position peaked at $12.4M in Q3 2020.
  • 384 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2025, filed 14 May 2025.